Medfinder
Back to blog

Updated: April 16, 2026

How to Help Your Patients Save Money on Levetiracetam: A Provider's Guide to Savings Programs

Author

Peter Daggett

Peter Daggett

Blog post header image for: How to Help Your Patients Save Money on Levetiracetam: A Provider's Guide to Savings Programs

A practical guide for providers on helping patients afford levetiracetam in 2026—covering insurance tiers, GoodRx comparisons, patient assistance, and copay optimization strategies.

Medication cost is a major driver of non-adherence in epilepsy—and for a condition where missing even a single dose can trigger a seizure, adherence is not optional. Fortunately, levetiracetam is one of the more affordable AEDs available, particularly in generic form. This guide gives prescribers the knowledge to actively help patients minimize what they pay for levetiracetam.

The Cost Landscape for Levetiracetam in 2026

Understanding price ranges helps you counsel patients accurately:

  • Generic IR tablets (500 mg, 30-day supply) retail cash price: $65–$153 without any discount
  • With GoodRx coupon: As low as $6.12 (91% off retail average)
  • With SingleCare coupon: As low as $6.46 for 60 tablets (500 mg)
  • Generic XR tablets with GoodRx: As low as $15.60
  • Insurance copay (generic, Tier 1–2): $0–$30 for most commercial plans and Medicare Part D

Strategy 1: Always Prescribe Generic

Generic levetiracetam is FDA-approved as bioequivalent to brand Keppra and is dramatically less expensive. Unless there is a documented medical reason for brand-only (e.g., documented sensitivity to specific inactive ingredients that differs between brand and generic), always prescribe "levetiracetam" (generic allowed / DAW 0). This gives patients maximum pricing flexibility.

If a patient is on brand Keppra for historical reasons and is stable, consider initiating a conversation about switching to generic—the cost savings can be substantial and the clinical risk is low when done with proper monitoring.

Strategy 2: Educate on Prescription Discount Coupons

Many patients don't know that prescription discount coupons (GoodRx, SingleCare, Blink Health, RxSaver) can often cost less than their insurance copay—even for well-insured patients. For levetiracetam, a GoodRx coupon can bring the cost to $6–$7 for a 30-day supply, which is frequently less than the Tier 1 or Tier 2 copay for patients with high-deductible plans.

Key point: Coupons cannot be combined with insurance. Patients must choose one or the other at the point of sale. Encourage patients to ask their pharmacist to run both their insurance and a GoodRx price, then choose the lower of the two.

Strategy 3: Prescribe 90-Day Supplies via Mail Order

Mail-order pharmacy offers several financial advantages for chronic medications:

  • Many insurance plans offer 3 months for the price of 2 copays when using mail-order pharmacy
  • Fewer pharmacy trips = fewer opportunities to run into stock-outs
  • Mail-order pharmacies typically have larger buffer stock and are less susceptible to local spot shortages

Prescribe 90-day quantities for all stable levetiracetam patients. Include the language "90-day supply, mail order preferred" on the prescription.

Strategy 4: Know the Insurance Coverage Landscape

Generic levetiracetam is covered by virtually all commercial insurance plans and Medicare Part D plans, typically at Tier 1 or Tier 2. Prior authorization is uncommon for the generic formulation. However:

  • Brand Keppra or Spritam may require prior authorization or step therapy (requiring trial of generic first)
  • Some Medicaid plans have quantity limits on AEDs — be aware if prescribing high doses
  • Medicare Part D now has a $2,000 annual out-of-pocket cap (2025 forward), providing significant protection for patients on multiple medications

Strategy 5: Patient Assistance Programs for Brand Keppra and Spritam

For patients who require brand formulations (Keppra, Spritam) and cannot afford them:

  • UCB Patient Assistance Program: UCB Pharmaceuticals (Keppra manufacturer) offers assistance programs for qualifying uninsured/underinsured patients. Contact: 1-800-UCB-5555.
  • NeedyMeds.org and RxAssist.org: Comprehensive databases of patient assistance programs across all manufacturers. Point patients to these resources.
  • State pharmaceutical assistance programs: Many states have programs for low-income patients—check your state's health department resources.

Strategy 6: Recommend medfinder to Reduce Shortage Calls

While not directly a cost-savings tool, recommending medfinder helps patients quickly locate pharmacies with levetiracetam in stock. This reduces costly and stressful situations where patients run out and need emergency prescriptions or urgent care visits—an indirect but meaningful cost savings. Visit medfinder.com/providers to learn more about recommending medfinder to your patients.

Quick Reference: Levetiracetam Cost Reduction Summary for Prescribers

  1. Always prescribe generic levetiracetam (DAW 0) unless medically contraindicated
  2. Tell all levetiracetam patients to compare GoodRx/SingleCare vs. their insurance copay at every fill
  3. Prescribe 90-day supplies with mail-order for all stable patients
  4. Refer uninsured patients to NeedyMeds.org and UCB patient assistance for brand versions
  5. Recommend medfinder to help patients quickly find stock—avoiding emergency situations that drive up cost

Frequently Asked Questions

No manufacturer-sponsored copay card program is currently available for generic levetiracetam, as generic drugs typically don't have manufacturer support programs. For brand Keppra or Spritam, UCB Pharmaceuticals offers patient assistance for qualifying uninsured or underinsured patients—not traditional copay cards. Prescription discount cards (GoodRx, SingleCare) are the best tool for reducing out-of-pocket costs for the generic.

Yes, but coupons and insurance cannot be used together at the same time. Patients pay either their insurance copay or the GoodRx/SingleCare price—whichever is lower. For generic levetiracetam, the coupon price ($6–$7 for a 30-day supply) is often lower than insurance copays, especially for patients with high-deductible plans or before their deductible is met. Encourage patients to compare both.

Yes. Generic levetiracetam is covered by Medicare Part D prescription drug plans, typically at Tier 1 or Tier 2. Most Medicare Part D plans cover it with a copay of $0–$15 for Tier 1 or $15–$45 for Tier 2, depending on the plan. Since 2025, Medicare Part D has a $2,000 annual out-of-pocket cap. Brand Keppra may not be covered or may require step therapy on Medicare plans.

For uninsured patients, the combination of a GoodRx coupon and a 90-day supply from a mail-order pharmacy can bring costs to under $20/month for generic levetiracetam. For patients who genuinely cannot afford even the discounted generic, refer to NeedyMeds.org or the Extra Help program (Low Income Subsidy) for Medicare patients, which can reduce Part D costs to near zero for qualifying individuals.

This is a reasonable discussion to have with stable patients. Generic levetiracetam is FDA-approved as bioequivalent to brand Keppra. The cost savings can be substantial (80–90% reduction). However, some neurologists are cautious about switching stable, seizure-free patients given the consequences of breakthrough seizures. When switching is considered, do so with close follow-up over the first 1–3 months and counsel patients to report any changes in seizure control immediately.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Levetiracetam also looked for:

30,258 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,258 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?